Search for: "Ex parte Abbott Laboratories and Abbott Laboratories, Inc." Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2013, 10:12 pm by Lawrence B. Ebert
Cerveceria India, Inc.,892 F.2d 1021, 1023 (Fed. [read post]
13 Aug 2019, 9:01 pm by Samuel Estreicher
The court of appeals in State of Texas is simply ignoring the threshold inquiry that was Part I of the Abbott Laboratories decision—does the statute in question preclude pre-enforcement review? [read post]
15 Mar 2007, 6:33 am
Abbott Laboratories, Inc., 2006 WL 3457617, *12 (D. [read post]
24 Nov 2010, 8:22 am by Stefanie Levine
And the following ex parte requests were filed: (1) 90/011,332 (electronically filed) - U.S. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
6 Feb 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: WTO report confirms USTR lost on key issue of whether China’s thresholds for criminal IP enforcement are too high (Managing Intellectual Property) (IP Justice) (IP Justice) (China Hearsay) (China Law Blog) US: Judd Gregg to be nominated as Secretary of Commerce (Inventive Step) (IP Watchdog) (Peter Zura's 271 Patent Blog)… [read post]
28 Dec 2012, 1:57 pm by Bexis
  Courts and the common law are part of the government, and thus equally subject to First Amendment limits, as we discussed here. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
When necessary as part of its duties, the agency must occasionally make sure that some of these unsafe products are removed from public circulation through its recall process. [read post]